354 related articles for article (PubMed ID: 25613066)
21. lncRNAs as potential molecular biomarkers for the clinicopathology and prognosis of glioma: A systematic review and meta-analysis.
Zhou Q; Liu J; Quan J; Liu W; Tan H; Li W
Gene; 2018 Aug; 668():77-86. PubMed ID: 29777909
[TBL] [Abstract][Full Text] [Related]
22. Long non-coding RNA HOTTIP is correlated with progression and prognosis in tongue squamous cell carcinoma.
Zhang H; Zhao L; Wang YX; Xi M; Liu SL; Luo LL
Tumour Biol; 2015 Nov; 36(11):8805-9. PubMed ID: 26058875
[TBL] [Abstract][Full Text] [Related]
23. MALAT1 is a prognostic factor in glioblastoma multiforme and induces chemoresistance to temozolomide through suppressing miR-203 and promoting thymidylate synthase expression.
Chen W; Xu XK; Li JL; Kong KK; Li H; Chen C; He J; Wang F; Li P; Ge XS; Li FC
Oncotarget; 2017 Apr; 8(14):22783-22799. PubMed ID: 28187000
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of long noncoding RNA MALAT1 in various carcinomas: evidence from nine studies.
Xue Y; Teng YQ; Zhou JD; Rui YJ
Tumour Biol; 2016 Jan; 37(1):1211-5. PubMed ID: 26282005
[TBL] [Abstract][Full Text] [Related]
25. A Long Noncoding RNA ZEB1-AS1 Promotes Tumorigenesis and Predicts Poor Prognosis in Glioma.
Lv QL; Hu L; Chen SH; Sun B; Fu ML; Qin CZ; Qu Q; Wang GH; He CJ; Zhou HH
Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27589728
[TBL] [Abstract][Full Text] [Related]
26. Long non-coding RNA MALAT1 is an independent prognostic factor of osteosarcoma.
Gao KT; Lian D
Eur Rev Med Pharmacol Sci; 2016 Sep; 20(17):3561-5. PubMed ID: 27649655
[TBL] [Abstract][Full Text] [Related]
27. The expression of lncRNA-MALAT1 in breast cancer patients and its influences on prognosis.
Sun Z; Liu J; Liu J
Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):72-78. PubMed ID: 32538750
[TBL] [Abstract][Full Text] [Related]
28. Potential role of circulating long noncoding RNA MALAT1 in predicting disease risk, severity, and patients' survival in sepsis.
Geng F; Liu W; Yu L
J Clin Lab Anal; 2019 Oct; 33(8):e22968. PubMed ID: 31301104
[TBL] [Abstract][Full Text] [Related]
29. lncTCF7 is a negative prognostic factor, and knockdown of lncTCF7 inhibits migration, proliferation and tumorigenicity in glioma.
Gao X; Guo X; Xue H; Qiu W; Guo X; Zhang J; Qian M; Li T; Liu Q; Shen J; Deng L; Li G
Sci Rep; 2017 Dec; 7(1):17456. PubMed ID: 29234033
[TBL] [Abstract][Full Text] [Related]
30. Expression of long non-coding RNA CRNDE in glioma and its correlation with tumor progression and patient survival.
Jing SY; Lu YY; Yang JK; Deng WY; Zhou Q; Jiao BH
Eur Rev Med Pharmacol Sci; 2016 Oct; 20(19):3992-3996. PubMed ID: 27775801
[TBL] [Abstract][Full Text] [Related]
31. MALAT1 long non-coding RNA is overexpressed in multiple myeloma and may serve as a marker to predict disease progression.
Cho SF; Chang YC; Chang CS; Lin SF; Liu YC; Hsiao HH; Chang JG; Liu TC
BMC Cancer; 2014 Nov; 14():809. PubMed ID: 25369863
[TBL] [Abstract][Full Text] [Related]
32. Malat1 activates autophagy and promotes cell proliferation by sponging miR-101 and upregulating STMN1, RAB5A and ATG4D expression in glioma.
Fu Z; Luo W; Wang J; Peng T; Sun G; Shi J; Li Z; Zhang B
Biochem Biophys Res Commun; 2017 Oct; 492(3):480-486. PubMed ID: 28834690
[TBL] [Abstract][Full Text] [Related]
33. Prognostic and clinicopathological significance of long non-coding RNA in glioma.
Li J; Liang R; Song C; Xiang Y; Liu Y
Neurosurg Rev; 2020 Feb; 43(1):1-8. PubMed ID: 29564570
[TBL] [Abstract][Full Text] [Related]
34. Association of long non-coding RNA HOTTIP with progression and prognosis in colorectal cancer.
Ren YK; Xiao Y; Wan XB; Zhao YZ; Li J; Li Y; Han GS; Chen XB; Zou QY; Wang GC; Lu CM; Xu YC; Wang YC
Int J Clin Exp Pathol; 2015; 8(9):11458-63. PubMed ID: 26617875
[TBL] [Abstract][Full Text] [Related]
35. MDC1-AS, an antisense long noncoding RNA, regulates cell proliferation of glioma.
Yue H; Zhu J; Xie S; Li F; Xu Q
Biomed Pharmacother; 2016 Jul; 81():203-209. PubMed ID: 27261595
[TBL] [Abstract][Full Text] [Related]
36. Long non-coding RNA MALAT1 as a valuable biomarker for prognosis in osteosarcoma: A systematic review and meta-analysis.
Liu M; Yang P; Mao G; Deng J; Peng G; Ning X; Yang H; Sun H
Int J Surg; 2019 Dec; 72():206-213. PubMed ID: 31734255
[TBL] [Abstract][Full Text] [Related]
37. Clinical Significance of Long Non-coding RNA MALAT1 Expression in Tissue and Serum of Breast Cancer.
Miao Y; Fan R; Chen L; Qian H
Ann Clin Lab Sci; 2016 Jul; 46(4):418-24. PubMed ID: 27466303
[TBL] [Abstract][Full Text] [Related]
38. Aberrant expression of long noncoding RNAs in colorectal cancer with liver metastasis.
Ye LC; Ren L; Qiu JJ; Zhu DX; Chen T; Chang WJ; Lv SX; Xu J
Tumour Biol; 2015 Nov; 36(11):8747-54. PubMed ID: 26050227
[TBL] [Abstract][Full Text] [Related]
39. LncRNA CPS1-IT1 serves as anti-oncogenic role in glioma.
Chen H; Li Q; Liang J; Jin M; Lu A
Biomed Pharmacother; 2019 Oct; 118():109277. PubMed ID: 31545272
[TBL] [Abstract][Full Text] [Related]
40. High MALAT1 expression predicts a poor prognosis of cervical cancer and promotes cancer cell growth and invasion.
Yang L; Bai HS; Deng Y; Fan L
Eur Rev Med Pharmacol Sci; 2015 Sep; 19(17):3187-93. PubMed ID: 26400521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
